Gilead

(Image: Getty/daizuoxin)

Gilead taps HitGen for drug discovery

By Melissa Fassbender

Gilead and HitGen have signed a drug discovery collaboration – one of several recently announced agreements as HitGen sees increased demand for its technology, says CSO.

(Image: Getty/Claudiodivizia)

Hired and Retired: Leaving the room

By Ben Hargreaves

The industry has seen some high profile exits this month, with several individuals vacating, or being asked to vacate, positions on the C-suite.

(Image: Getty/Anghi)

GSK gets first approval for two-drug HIV treatment

By Ben Hargreaves

GSK’s Dovato is approved by the US FDA for the treatment of individuals with HIV with no previous antiretroviral therapy, in a first for a two-drug, fixed-dose, complete regimen.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers